LE FIGARO.
- Will the vaccines available to us be sufficient to vaccinate the entire planet?
To discover
Covid-19: what we know about the Delta variant
Covid-19: the third vaccine dose, instructions for use
Marie-Paule KIENY.
-
From a purely digital point of view Pfizer and Moderna ensure that they have sufficient production capacity to do so.
But by having only a few vaccines we run the risk of monopoly.
Read also
Are anti-Covid vaccines the cause of 25,000 deaths in Europe?
For the moment the manufacturers have agreed to restrict themselves during the pandemic, but have already started to increase their prices.
The production costs of an RNA vaccine do not exceed € 2.50 per dose, but they are already sold between € 15 and € 20.
Competition is the best tool to limit this increase.
There is therefore every interest in increasing the offer to guarantee access to as many people as possible.
These vaccines are extremely effective, is not any attempt at competition in vain?
RNA vaccines are great, but they are not very stable at room temperature.
Progress has been made, but storage conditions remain restrictive and complicate
This article is for subscribers only.
You have 52% left to discover.
Pushing back the limits of science is also freedom.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in